细胞凋亡检测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

细胞凋亡检测市场按产品(检测试剂盒、试剂、仪器和微孔板)、检测技术、应用、最终用户和地理划分

市场快照

Apoptosis Assay Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.3 %
Apoptosis Assay Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

导致细胞凋亡检测市场增长的主要因素是传染病和慢性疾病(如自身免疫性疾病、癌症等)的发病率不断上升。患有慢性和自身免疫性疾病的人口增加正在推动对市场增长的需求。2018 年,根据 AARDA(美国自身免疫相关疾病协会)的统计数据,约有 5000 万美国人患有自身免疫性疾病,预计未来这一数字还会上升。在将细胞凋亡检测市场提升到一个新的水平方面,几乎没有其他因素在发挥关键作用,其中一个是与细胞凋亡调节药物相关的持续发展,预计将进一步推动全球细胞凋亡检测市场的增长. 然而,对癌症的高内涵诊断和临床研究的需求不断增加,

报告范围

细胞凋亡是发生在多细胞生物中的一种程序性细胞死亡形式。Apoptosis Assay 旨在检测细胞是否发生凋亡。它识别和量化与程序性细胞死亡相关的细胞事件,包括半胱天冬酶启动、磷脂酰丝氨酸 (PS) 细胞表面暴露和 DNA 片段化。

By Product
Assay Kits
Annexin V
Caspase Assay
Others
Reagents
Instruments
Microplates
By Detection Technology
Spectrophotometry
Flow Cytometry
Cell Imaging and Analysis Systems
Other Technology
By Application
Stem Cell Research
Clinical and Diagnostics Application
Drug Discover and Development
Others
By End User
Pharmaceutical and Biotechnology Companies
Hospitla and Laboratories
Academic and Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

检测试剂盒细分市场有望在细胞凋亡检测市场中占有最大的市场份额

  • 检测试剂盒可识别和量化与程序性细胞死亡相关的细胞事件,包括半胱天冬酶启动、磷脂酰丝氨酸 (PS) 细胞表面暴露和 DNA 片段化。
  • 在许多其他细胞凋亡过程中重复消耗的检测数量可以推动预测期内检测试剂盒的需求。
  • 自身免疫性疾病、癌症等传染病和慢性病发病率的上升也推动了市场的增长。根据 GLOBOCAN 2018 的统计数据,全球有 18,078,957 人患有癌症。亚洲仍然是癌症发病率上升的主要贡献者,据报道份额为 48.4%,其次是欧洲、北美和拉丁美洲、非洲和大洋洲,份额分别为 23.4%、13.2% 和 7.8%、5.8% 和 1.4%分别。
Apoptosis Assay Market Size

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个细胞凋亡检测市场。这是由于癌症等慢性病发病率上升以及先进医疗基础设施的可用性等主要因素。在北美地区,由于自身免疫性疾病和慢性病患者人数的增加,以及该国老年人口的增加和细胞凋亡调节药物相关的发展等因素,美国占据了最大的市场份额。预计将刺激该地区的需求。

Apoptosis Assay Market Share

竞争格局

细胞凋亡检测市场竞争适度,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。Ans 一些知名企业正在积极与其他公司进行收购和新产品发布,以巩固其在全球的市场地位。目前主导市场的一些公司是 Thermo Fisher Scientific、Bio-Rad Laboratories、Merck KGaA、GE Healthcare 和 Becton, Dickinson and Company。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Chronic and Autoimmune Diseases

      2. 4.2.2 Developments Related to Apoptosis-Modulating Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Reforms

      2. 4.3.2 Expensive Detection Technology and High Capital Investment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Assay Kits

        1. 5.1.1.1 Annexin V

        2. 5.1.1.2 Caspase Assay

        3. 5.1.1.3 Others

      2. 5.1.2 Reagents

      3. 5.1.3 Instruments

      4. 5.1.4 Microplates

    2. 5.2 By Detection Technology

      1. 5.2.1 Spectrophotometry

      2. 5.2.2 Flow Cytometry

      3. 5.2.3 Cell Imaging and Analysis Systems

      4. 5.2.4 Other Technology

    3. 5.3 By Application

      1. 5.3.1 Stem Cell Research

      2. 5.3.2 Clinical and Diagnostics Application

      3. 5.3.3 Drug Discover and Development

      4. 5.3.4 Others

    4. 5.4 By End User

      1. 5.4.1 Pharmaceutical and Biotechnology Companies

      2. 5.4.2 Hospitla and Laboratories

      3. 5.4.3 Academic and Research Institutes

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Bio-Rad Laboratories

      4. 6.1.4 GE Healthcare

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Sartorius AG

      7. 6.1.7 GeneCopoeia, Inc.

      8. 6.1.8 BioTek Instruments

      9. 6.1.9 Bio-Techne Corporation

      10. 6.1.10 PerkinElmer Inc.

      11. 6.1.11 Promega Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Apoptosis Assay Market market is studied from 2018 - 2026.

The Apoptosis Assay Market is growing at a CAGR of 9.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Becton, Dickinson and Company are the major companies operating in Apoptosis Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!